Table 2 Baseline and Changes from Baseline in Total Cholesterol, LDL-C, HDL-C, Triglycerides, TC:HDL Ratio, Apo A and Apo B after 6 Weeks of Treatment with either the Combination of Ezetimibe plus Fenofibrate or Atorvastatin Monotherapy
| Â | Ezetimibe plus Fenofibrate | Atorvastatin Monotherapy | Â | Â | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Baseline | 6 Weeks | % Change | p Value | Baseline | 6 Weeks | % Change | p Value | % Difference | p Value |
Total Chol (mmol/L) | 5.9 | 4.4 | -25.1 | < 0.001 | 5.8 | 4.4 | -24.6 | < 0.001 | -0.4 | 0.806 |
LDL-C (mmol/L) | 3.8 | 2.4 | -34.6 | < 0.001 | 3.7 | 2.3 | -36.7 | < 0.001 | 2.1 | 0.46 |
HDL-C (mmol/L) | 1.4 | 1.5 | 10.0 | 0.002 | 1.3 | 1.5 | 8.9 | 0.006 | 1.1 | 0.778 |
Triglycerides (mmol/L) | 1.5 | 1.0 | -25.4 | < 0.001 | 1.6 | 1.4 | -14.5 | 0.002 | -11.0 | 0.079 |
TC:HDL Ratio | 4.3 | 3.0 | -29.0 | < 0.001 | 4.4 | 3.1 | -28.7 | < 0.001 | -0.2 | 0.904 |
Apo A | 1.27 | 1.32 | 4.5 | 0.041 | 1.29 | 1.30 | 1.5 | 0.493 | 3.04 | 0.295 |
Apo B | 1.21 | 0.82 | -31.8 | < 0.001 | 1.19 | 0.82 | -29.8 | < 0.001 | -1.99 | 0.392 |